π Entity
Duchenne muscular dystrophy
Type of muscular dystrophy
π Rating
1 news mentions Β· π 0 likes Β· π 0 dislikes
π Topics
- Stock Market Analysis (1)
- Biotechnology Clinical Trials (1)
- Investment Outlook (1)
π·οΈ Keywords
Guggenheim (1) Β· PepGen (1) Β· Stock Price Target (1) Β· Clinical Trials (1) Β· Biotechnology (1) Β· Pharmaceutical Investments (1) Β· PepFect Technology (1) Β· Neurological Disorders (1)
π Key Information
Duchenne muscular dystrophy (DMD) is a severe type of muscular dystrophy predominantly affecting boys. The onset of muscle weakness typically begins around age four, with rapid progression. Initially, muscle loss occurs in the thighs and pelvis, extending to the arms, which can lead to difficulties in standing up.
π° Related News (1)
π Entity Intersection Graph
People and organizations frequently mentioned alongside Duchenne muscular dystrophy:
-
Clinical trial Β· 1 shared articles -
Biotechnology Β· 1 shared articles -
π
Guggenheim Β· 1 shared articles